24 March 2021
The Isle of Wight is first to implement the Dermicus teledermatology platform for early diagnosis of skin cancer. Following a successful implementation, Gnosco’s collaboration with the NHS was in November 2020 shortlisted for the NHS 2020 HSJ Awards – Primary Care Innovation of the Year as one of eight finalists.
March 17, at a virtual ceremony, the winners of the NHS HSJ Awards 2020 were announced. Congratulations to the winner in the category – Primary Care Innovation of the Year: Sevenhills + Primary Care Network – Covid-19 Vulnerable Patient Visiting Service.
“We are very proud and honored that our NHS team: Gnosco, Isle of Wight CCG, Isle of Wight Trust, Lighthouse Medical and Wessex Academic Health Science Network (AHSN) were selected as one of eight finalists. The IOW NHS team is also first to implement Dermicus at all their health centres. It naturally inspires the continued development and implementation of teledermatoscopy as a valuable digital decision support for healthcare providers,” said Daniel Eliasson, CEO, Gnosco.
“Early diagnosis of cancer is key to survival efforts, and General Practice and Primary Care Networks play a crucial role in helping support both patients and colleagues in secondary care to do this. A dedicated teledermatology platform, with clear visuals and that is easy-to-use, can help dermatology services to be more effective. The Dermicus solution is an excellent innovative example of digital technology transforming patient care and is supporting the earlier diagnosis of cancer. Being shortlisted in the Primary Care Innovation Category at the HSJ Awards is testament to this,” said Rachel Dominey, Associate Director of Primary Care Innovation, Wessex AHSN.
The HSJ Awards is an annual competition with a long tradition and in 2020, they celebrate their 40th anniversary. It is one of the largest healthcare awards in the world, initiated by the NHS Health Service Journal (HSJ), and aims to reward innovation and new ways of working that can shape the future of the NHS.
The Isle of Wight has a population of 144.000, and jointly through the CCG and NHS Trust, it is first to implement the Dermicus teledermatology platform for the early diagnosis of skin cancer. Since May 2020 all the 14 GP practices on the island is using the platform.
The implementation on the Isle of Wight started in July 2019, and an independent evaluation report by Wessex AHSN of the platform was published in April 2020, Interim Independent Evaluation of Dermicus Telemedicine Platform in IOW Primary Care, Wessex AHSN, Real World Validation Report. The report states that the average wait from referral to first consultant review using the traditional pathway was 26 days, for referrals that have been through the Dermicus platform the wait time is 0.6 days. 45% of patients were able to be managed using remote advice and guidance only, reducing unnecessary outpatient appointments and reducing patient anxiety. 30% were able to be booked directly to biopsy, reducing the need for an initial appointment to determine whether biopsy was necessary. Given the positive experiences of teledermatology the Isle of Wight CCG and NHS Trust is considering implementation of the Dermicus platform to also support the management of wound care on the Island.
Read more about to the nomination of the team in November 2020 in this news post “Shortlisted for NHS Primary Care Innovation of the Year”.
The IOW NHS in UK and Region Stockholm Sweden are together first to implement Dermicus at all their health centres. Read more in this press release January 27, 2021.